-
Personal Insect repellents
Learn about personal insect repellents; how to use them safely and how to choose the right one for your needs. -
Health product advertising incidents related to COVID-19
Health Canada is taking urgent measures to protect consumers from illegal, false or misleading advertising of products claiming to mitigate, prevent, treat, diagnose, or cure... -
Health Canada’s Proposal to Add Maximum Levels for Inorganic Arsenic in...
Food contaminants and other adulterating substances are chemicals that may be present in foods at levels that could impact the overall safety and/or quality of foods. These... -
Guidance on safety and performance specifications for filtering facepiece...
The Interim Order (IO) expedites the authorization of Class I to IV medical devices used for COVID-19: sets out the safety, effectiveness and quality requirements for filtering... -
Final Guidance Document Data Requirements for Safety and Effectiveness of...
This guidance is intended to assist sponsors in the collection and analysis of data for Steroid Nasal products for use in the treatment of allergic rhinitis, in order to meet... -
Proposed Special Review Decision PSRD2020-04, Special Reviews of Pymetrozine...
Before making a special review decision on pymetrozine, Health Canada will consider all comments received from the public in response to PSRD2020-04. A science-based approach... -
Exceptional importation and sale of drugs in relation to COVID-19: For industry
There is an unprecedented demand and urgent need for access to medical devices during the COVID-19 pandemic. On March 30, 2020, the Minister of Health signed the Interim Order... -
Occupational Radiation Exposures in Canada
The National Dose Registry (NDR) is Canada’s national repository for dose records of Canadian workers who are monitored for occupational exposure to ionizing radiation. -
Foreign risk notification for medical devices guidance document: Monitoring,...
Requirements for manufacturers and importers for collecting medical device safety information and provide notification to Health Canada. A monitoring process should be in place... -
Relevant exemptions to the Controlled Drugs and Substances Act
Between 2018 and 2020, Health Canada has issued a number of exemptions to the Controlled Drugs and Substances Act. Some of the exemptions have been issued to maintain Canadians'... -
About cells, tissues and organs (CTO) inspections
Learn how we conduct inspections of human cell, tissue and organ (CTO) establishments. -
Food safety tips for mushrooms
There are many types of edible mushrooms, including white button mushrooms, portabella mushrooms, and shiitake mushrooms. By making sure they are properly handled, washed,... -
Products susceptible to illegal marketing: Illegal marketing of medical devices
Requirements for marketing medical devices, what to watch for, and how you can help -
Product monograph brand safety updates
Label safety assessment update from Health Canada -
Qualifying Notice: Retevmo
This Notice of Compliance with Conditions Qualifying Notice (NOC/c-QN), issued in accordance with the Health Canada Guidance Document. -
Whole Algal Flour to be used as a partial replacement for cream, milk,...
In 2014, Health Canada received a submission to allow the sale of Whole Algal Flour to be used as a partial replacement for cream, milk, eggs/egg yolks and butter/shortening in... -
Guidelines for Canadian Drinking Water Quality: Guideline Technical Document...
This guideline technical document reviews and assesses all identified health risks associated with chromium in drinking water. It incorporates new studies and approaches and... -
Draft guidance on improving indoor air quality in office buildings:...
Indoor air quality (IAQ) is a recognized health and safety issue. Indoor air quality issues may occur in buildings when chemical and biological contaminants exist at levels that... -
Guidance on applications for COVID-19 drug clinical trials under the...
This section of the guidance outlines the additional requirements for good clinical practices, qualified investigators, and labelling. -
Summary Safety Review - INTUNIV XR (guanfacine hydrochloride) - Assessing...
A safety review was carried out to evaluate the potential risk of Raynaud's phenomenon in patients taking Intuniv XR. Raynaud's phenomenon is a disorder of the blood vessels,...